Richard Kim, MD / Gerald Prager, MD - Evidence-Based Strategies for Optimizing Long-Term Treatment Responses in Later Lines of mCRC Care

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Essentials: Optimal Protocols to Build Strength & Grow Muscles | Dr. Andy Galpin 37 min · 24 Sep 2026 · Huberman Lab

307. Dr. Josh Axe, Dr. Will Cole & Taylor Dukes: Toxoplasma Gondii Is Linked to Brain Tumors 33 min · 24 Sep 2026 · The Ultimate Human with Gary Brecka

A Grand Canyon Mishap, "Rain" in Ireland, & an Airport Disaster: Listener Episode #28 45 min · 24 Sep 2026 · Family Trips with the Meyers Brothers

3AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

443: Caleb Flynn Trial, RC Horsch New Victims, KJ Biermann Updates & More Siders Family News 1h 6m · 24 Sep 2026 · Serialously with Annie Elise

Jean-Claude Romand: Lies that Led to Murder Pt. 2 1h 0m · 24 Sep 2026 · Serial Killers & Murderous Minds

Report any issue

Source

Recorded28 Oct 2024

Publisherc.answersincme.com ↗

Handlerec:766017

Show notes

Please visit answersincme.com/TBY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in colorectal cancer discuss management of patients with metastatic disease in the third line and beyond. Upon completion of this activity, participants should be better able to: Identify guideline recommendations for later-line treatments for patients with metastatic colorectal cancer (mCRC); Review the clinical implications of the latest evidence for later-line treatments for patients with mCRC; and Outline evidence-based approaches to improve long-term response rates in later-line treatment of mCRC.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in